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Pregnancy and STD Prevention Counseling Using
An Adaptation ofMotivational Interviewing:
A Randomized Controlled Trial
CONTEXT: Given levels of unintended pregnancy and STDs, an effective counseling intervention is needed to improve
women’s consistent use of effective prevention methods.
METHODS: A sample of 764 women aged 16–44 who were at risk of unintended pregnancy were enrolled in a
randomized controlled trial in North Carolina in 2003–2004. Intervention participants received pregnancy and STD
prevention counseling, adapted from motivational interviewing, both at enrollment and two months later; controls
received only a session of general health counseling. Levels of contraceptive use (categorized as high, low or none on
the basis of the effectiveness of the method and the consistency of use) and barriers to use were measured at two, eight
and 12 months; chi-square tests were used to compare selected outcomes between the groups. Rates of unintended
pregnancy and chlamydia infection were assessed over the study period.
RESULTS: At baseline, 59% of all participants reported a high level of contraceptive use, 19% a low level and 22% nonuse.
At two months, the proportions of intervention and control participants who had improved their level of use or
maintained a high level (72% and 66%, respectively) were significantly larger than the proportions who had reported
a high level of use at baseline (59% and 58%, respectively). No significant differences were found between the
groups at 12 months, or between baseline and 12 months for either group. During the study, 10–11% of intervention and
control participants became pregnant, 1–2% received a chlamydia diagnosis and 7–9% had another STD diagnosed.
CONCLUSIONS: Repeated counseling sessions may be needed to improve contraceptive decision-making and to reduce
the risk of unintended pregnancy and STDs.
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Women’s health status in the United States is adversely
affected by the occurrence of unintended pregnancies
and STDs. Approximately half of all pregnancies in the
United States are unintended at the time of conception,1,2
and these pregnancies are associated with higher rates of
induced abortion2–4 and low-birth-weight infants,5 late
initiation of prenatal care,6 use of harmful substances
such as tobacco and alcohol during pregnancy,3 and
increased risk of domestic violence.7 An estimated 19
million new STDs occur each year in the United States,8
and these infections put women at risk for long-term
complications, including AIDS, pelvic inflammatory dis-
ease, ectopic pregnancy and infertility.9
More than half of all unintended pregnancies occur
among the 7% of women who do not use any contracep-
tive method and yet do not want, or are not trying, to get
pregnant.3 Women of all reproductive ages report con-
traceptive nonuse,3,10–13 and many women with unin-
tended pregnancies also report inconsistent use, or use of
an ineffective method. Nonuse and inconsistent use of
condoms put these women at risk of contracting STDs.
Health care providers are in a unique position to
counsel women about behaviors that place them at risk
of unintended pregnancy and STDs. Prevention strategies
should include attention to specific risk-taking behaviors
and should emphasize targeted risk reduction counseling
for all sexually active women.14,15 Such counseling should
cover contraceptive use patterns (e.g., consistency of
method use and effectiveness of method) and risk-taking
behaviors (e.g., having multiple partners, having unpro-
tected sex, having sexwith partners who are at risk ofHIV
or other STDs).16 Contraceptive behaviors may be the
risk factors that are most amenable to change through a
health care visit. Consistent and correct use of contracep-
tives is the primary determinant of their effectiveness.17
Although health care providers can offer counseling on
patterns of contraceptive use and risky behaviors, the
opportunity is often missed. A minority of providers
adequately counsel women on their contraceptive needs,
and providers often fail to ask about pregnancy intention,
sexual risk-taking behaviors, or the need for pregnancyor
disease prevention.18–20 Providers have described several
barriers to giving reproductive health counseling that
are similar tobarriers to offering general preventive health
counseling—time restraints, inadequate reimbursement,
lackof perceivedneed (byboth clients andproviders) and
lack of training to address sensitive reproductive health
issues.21–25
No standardized intervention in routine clinical care
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that might lead to a decrease in unintended pregnancies
and STDs.26 Although a number of interventions have
targeted HIV and STD prevention in both domestic
and international settings, most have not considered a
woman’s pregnancy intentions in counseling or effectively
incorporated behavioral theory to address sexual risk-
taking behaviors. The few interventions that have been
informed by successes in other areas of health promotion
have generally been implemented for specific high-risk
clients outside of clinical settings (e.g., individuals in drug
treatment,27 those in high-risk communities28 or incar-
cerated individuals29). The structure of some of these in-
terventions (e.g., ranging from three four-hour sessions to
five 90-minute sessions27,30–32) limits the easewithwhich
they can be incorporated into standard clinical care.
One advance in behavioral counseling that providers
canuse to address the complexities of pregnancy andSTD
prevention counseling is motivational interviewing.33–35
This technique emphasizes the development of the
client’s self-efficacy36 with an appreciation for the differ-
ent stages that a client may go through in adopting a
health behavior,37 such as consistent use of an effective
contraceptive. Motivational interviewing, which was
developed by William Miller through his work in the
1970s and 1980swith problemdrinkers,33 can be used to
help clients recognize and potentially change behaviors
that put their health at risk. The approach stresses
empathy and reflective listening, while identifying dis-
crepancies between behaviors (e.g., inconsistent contra-
ceptive use) and broad goals (e.g., avoiding an unintended
pregnancy).33,35
To address the lack of a standardized and proven
counseling intervention in clinical settings, we evaluated
the effectiveness of a behavioral-based intervention de-
signed to reduce the risk and occurrence of unintended




This study was conducted at three primary care facilities
affiliated with the Department of Family Medicine of
the University of North Carolina at Chapel Hill. These
facilities serve clients of all ages, including more than
6,000 women of reproductive age, from numerous coun-
ties across centralNorthCarolina. At the beginning of this
study, 66% of female clients of reproductive age were
white, 27% were black and 6% were Asian, Hispanic or
American Indian. Approximately 10% paid for their care,
and 19% were covered by Medicaid.
To be eligible for enrollment in the study, women visit-
ing the clinics betweenMarch 2003 and September 2004
had to be 16–44 years old, at risk of unintended preg-
nancy (i.e., they were not pregnant and not planning
a pregnancy within a year, they were not using an IUD,
and neither they nor their partners were sterilized) and
interested in participating. The study was described to
potential participants as a ‘‘new information and coun-
seling program about reproductive health for women
who are NOT trying to get pregnant.’’ Prospective par-
ticipants gave written consent and provided a urine
sample for pregnancy testing and DNA probe testing for
chlamydia.
In this randomized controlled trial, the intervention
group received pregnancy and STD prevention counsel-
ing with a health educator at enrollment and twomonths
later in a booster session. The control group received
brief, general counseling at enrollment on preventive
health care (e.g., smoking, diet, exercise) that intention-
ally excluded counseling on pregnancy and STD pre-
vention; thesewomen received no further counseling.We
used a random-numbers table to generate group assign-
ments in permuted block sizes of 100, and placed sealed
envelopes with the assignments at each recruitment site.
Envelopes were opened after participants were screened
for eligibility, gave informed consent and tested negative
for being pregnant.
Participants completed self-administered baseline
questionnaires, which included questions on general
preventive health (e.g., smoking, exercise), contraceptive
use, perceivedbarriers to use, level of pregnancy intention
(i.e., wants to get pregnant now, wants to get pregnant in
the near future, does not want to be pregnant in the near
future, does not want to be pregnant, does not know) and
occurrence of recent pregnancies and STDs. These ques-
tionnaires had been developed and pilot-tested in a pop-
ulation of women similar to the study population, using
cognitive-response interviews, a qualitative evaluation
method.38
Participants completed follow-up questionnaires two,
eight and 12 months after enrollment. At the 12-month
follow-up, urine samples were collected for pregnancy
and chlamydia testing; after this follow-up, participants’
medical records were reviewed to assess their use of
reproductive health care services and counseling during
the study period. Women in both groups were compen-
sated $25 at the end of their participation. The study was
completed in September 2005. The biomedical institu-
tional review board of the University of North Carolina
at Chapel Hill approved the study protocol.
Women’s ReproductiveAssessmentProgram
The intervention—the Women’s Reproductive Assess-
ment Program (WRAP)—was delivered by experienced
health educators associated with and trained for this
project. It used a counseling model adapted from moti-
vational interviewing,39 following such principles as
expressing empathy and supporting self-efficacy.33 This
model emphasized three elements: exploring discrepan-
cies between pregnancy intention and contraceptive use,
and between STD risk and condom use; sharing informa-
tion with participants; and promoting behaviors to reduce
risk.35 To standardize the counseling, we provided edu-
cators with 30–40 hours of training on contraceptives,
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pregnancy and STD prevention counseling, motivational
interviewing, clinic operation, study design and imple-
mentation, and the basics of smoking cessation, exercise
and nutrition counseling. Quality control measures (e.g.,
random observation of counseling sessions, feedback
from the project manager) were used throughout the
study period.
The focus of the initialWRAP session was to encourage
women to adopt consistent, effective contraceptive use,
and condom use for the prevention of STD, including
HIV, infection. Health educators elicited information
about participants’ perceived barriers to consistent, effec-
tive contraceptive use (e.g., by asking what kinds of
situations made it hard to use a contraceptive method)
and their level of self-efficacy andmotivation for adopting
risk reduction behaviors (e.g., by exploring how sure they
were that they would use a contraceptive in the next 30
days). Educators used participants’ baseline responses to
evaluate pregnancy intention, contraceptive use patterns
and high-risk sexual behaviors, and to individualize their
counseling on contraceptive use and risk reduction
strategies.
For women who were already consistently using con-
traceptives for pregnancy prevention and condoms for
disease prevention, a risk reduction step might simply be
continuing current practice. For women with low self-
efficacy or those in an early stage of adopting consistent
and effective contraceptive use,33 risk reduction steps
might involve cognitive issues, such as improving com-
munication with partners. The initial session also offered
women the opportunity to obtain, or receive a referral for,
any type of contraceptive. If intervention participants
elected to start or change contraceptive methods, their
primary care provider was notified and the information
was added to their medical record.
Two months after the enrollment session, WRAP
health educators conducted a booster session either in
person or by telephone for intervention participants.
During this contact, educators focused on the client’s
progress toward or barriers to meeting specific risk
reduction steps and adopting consistent, effective contra-
ceptive and condom use. We selected two months as the
time for the booster session and first follow-up to allow
participants ample time to make a behavior change; a
longer interval may have allowed them to forget the
counseling messages or become discouraged. No other
booster sessions were conducted, and the data collected
at eight and 12 months allowed us to evaluate the long-
term effect of the enrollment and booster sessions.
OutcomeMeasures
At baseline and at each follow-up, participants were asked
about all contraceptive methods used and, for each
method, their consistency of use in the last 30 days and
their intended use in the next 30 days. If a woman used
multiple methods, her most effective method, as deter-
mined from an established hierarchy of effectiveness,40
was considered her primary method. Women who used
condoms were asked about the consistency of use over
the last 30 days (every time they had sex, almost every
time, sometimes and almost never).
Level of contraceptive use was classified as high, low and
none. The high level denoted that a woman took an oral
contraceptive every day, consistently used the patch or
vaginal ring, used condoms every time or used depot
medroxyprogesterone acetate. The low level indicated that
she missed oral contraceptives; used the patch, vaginal ring
or male condom inconsistently; or used the diaphragm,
spermicides, withdrawal, emergency contraception or me-
thods based on fertility awareness. Women who reported
no contraceptive use were assigned to the nonuse level.
The primary outcome was change in the level of
women’s contraceptive use. If a woman increased the
level of her contraceptive use (i.e., a nonuser shifted to
either a low or high level, or a woman at the low level
shifted to the high level), or if shemaintained use at a high
level, she was considered to have improved her use or
maintained the highest level of use. If a woman decreased
the level of her contraceptive use (i.e., shifted from the
high level to the low level, or from the low level to
nonuse), or if she maintained a low level or nonuse, she
was not considered to have improved or maintained the
highest level of contraceptive use. For women who
reported condom use, we assessed whether use was
consistent (every time over the last 30 days).
Another measure was women’s reported barriers to a
high level of use. At baseline and at each follow-up,
participants were asked whether these or other situations
made it harder for themtousebirth control: useofdrugsor
alcohol, being too sexually aroused, partner’s getting angry,
too expensive to use, too difficult to obtain, too messy to
use, too busy to use, too nervous to use, religious reasons,
health problems or side effects caused by birth control.
At the eight-month follow-up, intervention participants
were asked about their level of satisfactionwithWRAPand
the health educators—whether it had been helpful to talk to
a counselor about contraception, whether the counselor
had focusedon their issues andwhether the counselor had
addressed all of their questions. The five potential re-
sponses ranged from strongly agree to strongly disagree.
Unintended pregnancy and chlamydia infection were
assessed for all participants over the 12-month study
period. Pregnancy and chlamydia tests were conducted at
enrollment and at the 12-month completion visit. At each
survey, women were asked whether they had had a pos-
itive pregnancy test or an STD since the last survey.
Medical charts were reviewed for each participant to
assess documentation of a pregnancy or diagnosis or
treatment of an STD during the study.
Statistical Analyses
We examined participants’ baseline characteristics, both
overall and by study group. The level of contraceptive
use was measured at baseline and at each follow-up.
Volume 39, Number 1, March 2007 23
Chi-square tests were used to compare differences in high
level of use and improvements in use between the
intervention and control groups at each survey. We
repeated these tests after stratifying by various sample
characteristics to examine effect modification terms.
Finally, we usedMcNemar’s chi-square test to assess high
level of use and improvement in use within the interven-
tion and control groups.
The sample size was intended to be large enough to
measure improvements in the level of women’s contra-
ceptive use over time. From our collective clinical and
research experience, we anticipated that the proportion
of womenwho improved use ormaintained a high level of
use would increase by 25% in the intervention group and
by 10% in the control group over the 12-month period.
With a powerof 90%(p=.05, two-sided),146womenwere
required in each study group. In addition, we planned to
recruit enough women to assess the occurrence of un-
intended pregnancy during the study. To calculate the
sample size needed for detecting potential differences, we
estimated rates of unintended pregnancy of 5% in the
intervention arm and 10% in the control arm. At 95%
power, we predicted we would need 948 participants.
Anticipating that 10% of participants would be lost to
follow-up over the study period, we set a minimum target
recruitment of 1,050 participants.
RESULTS
Participant Characteristics
From March 2003 to September 2004, a total of 4,101
women were screened for enrollment in the study. Of
these women, 1,066 refused, 2,034 were not eligible,
and 237were eligible but either were not interested or did
not have sufficient time to participate. Thus, 764 women
were eligible and interested, and provided informed
consent; 380 were randomly assigned to the intervention
group, and 384 to the control group. Of these partic-
ipants, 85% completed the two-month follow-up, 91%
completed the eight-month follow-up and 87% com-
pleted the 12-month follow-up; analysis was limited to
737 participants for whom complete follow-up data were
collected. We did not obtain an adequate sample size to
detect differences between the intervention and control
groups for unintended pregnancy and chlamydia infec-
tion, so we examined these as secondary outcomes.
Nearly six in 10 participants were between 26 and 44
years old, and the remainder were aged 16–25 (Table 1).
Thirty-two percent were currently married, 24% were
formerly married and 45% had never married. Eighty-
four percent had at least a high school education; 62%
were white, 27% black and 10% of another race or
ethnicity. Participants reported different levels of preg-
nancy intention: Sixty-four percent said they did not want
to get pregnant in the near future, 15% said they never
wanted to get pregnant and 21% did not know. Seven in
10 women reported having engaged in sexual intercourse
in the 30 days prior to enrolling in the study.
At enrollment, the most commonly used methods of
contraception were oral contraceptives (37%) and con-
doms (36%). Among women who had had sexual inter-
course in the 30 days prior to enrollment, consistent use
was reported by 94% of patch or vaginal ring users, 82%
of oral contraceptive users, 56% of condom users, 33%of
diaphragm or spermicide users, and 50% of those using
other methods (not shown).
In the baseline survey, 59% of women reported a high
level of contraceptive use, and 19% reported a low level of
use; 22% used no contraceptives. Among women report-
ing sexual intercourse in the 30 days before baseline, the
proportion reporting no use was 5%, and the proportion
reporting condom use was 49% (not shown).
At baseline, 57% of all participants reported barriers
to contraceptive use; the five most common barriers (not
TABLE 1. Percentagedistributionofwomenparticipating in
a pregnancy and STD prevention counseling study, by









16–25 41 40 41
26–44 59 60 59
Marital status
Currently married 32 34 30
Formerly married 24 20 27
Never-married 45 46 43
Education
<12th grade 16 17 15
$12th grade/GED 84 83 85
Race/ethnicity
White 62 65 60
Black 27 27 28
Other 10 8 12
Pregnancy intention
Not in near future 64 64 64
Not ever 15 17 14
Do not know 21 19 22
Had had sexual intercourse in last 30 days
Yes 70 71 69
No 30 29 31
Type of contraceptive*
Oral contraceptive 37 35 38
Condom 36 36 36
Injectable/implant 12 12 11
Patch/vaginal ring 6 6 6
Diaphragm/spermicide 3 2 3
Other 16 17 14
None 22 20 24
Level of contraceptive use†
High 59 59 58
Low 19 21 18
None 22 20 24
Barriers to using contraceptives
Yes 57 56 57
No 43 44 43
Total 100 100 100
*Multiple responses allowed. †Basedon themethod’s effectiveness and the
consistency of use; see page 23. Note: Percentages may not total 100%
because of rounding.
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shown) were forgetting to use (28%), side effects (19%),
being too sexually aroused (15%), alcohol use (13%) and
partner opposition (12%). Overall, women in the inter-
vention and control groups were similar in their social
and demographic characteristics, as well as their sexual
behavior and contraceptive use.
At the conclusion of the enrollment counseling session,
intervention participants selected one or more of the
following risk reduction steps: continue current method
(214), increase consistency of use (37), start or restart
a method (91), obtain medical follow-up (59) or think
about starting a method (132).
InterventionEffects
At the two-month follow-up, participants were asked
to report their success in completing their selected risk
reduction steps. Ninety percent reported success in
continuing their current method, 66% in increasing
their consistency of use, 75% in starting or restarting a
method, 47% in obtainingmedical follow-up for amethod
and 81% in thinking about starting a new method.
At the time of enrollment, the proportion of women in
the intervention group reporting a high level of contra-
ceptive use was 59%. Two months later, the proportion
who had either improved their level of use or maintained
a high level was 72% (p<.001—Figure 1). In the control
group, the proportions were 58% and 66%, respectively
(p<.05). However, the proportions at two months were
not significantly different between the groups. The pro-
portions of intervention and control participants who
improved their level of contraceptive use or maintained a
high level decreased at eight months to 63% and 62%,
respectively; again, the difference was not statistically
significant. At the 12-month follow-up, 64% of interven-
tion participants reported improvement or an ongoing
high level of contraceptive use, compared with 60% of
control participants; this difference was also not statisti-
cally significant.
Similarly, among participants who used condoms, the
proportion reporting consistent use did not differ
between the intervention and control groups at any point
in the study, and this proportion did not change signif-
icantly over the study period (not shown).
A significantly higher proportion of black women in
the intervention group than in the control group reported
improvement of contraceptive use or maintenance of a
high level of use at the two-month follow-up (72% vs.
55%; p<.05). A significant difference remained at the 12-
month follow-up (60%vs. 54%), although theproportion
for the intervention group declined over time. There was
no significant difference between proportions of inter-
vention and control participants aged 16–25 years who
reported improvement or a high level of use at the two-
month follow-up (80% vs. 67%). No differences or trends
were found in contraceptive use when participants were
analyzed by marital status, education level or pregnancy
intention.
Among women reporting no barriers to contraceptive
use, the proportion who improved or maintained a high
level of use during the first two months of the study was
significantly higher in the intervention than in the control
group (84% vs. 73%; p=.01—Figure 2). The proportions
did not differ significantly at eight or 12 months. Among
women who reported barriers to contraceptive use, there
were negligible differences at all time points between
the proportions of intervention and control participants
who improved or maintained a high level of use (Figure 3,
page 26).
During the 12-month study, 10% of participants
became pregnant, 1% received a chlamydia diagnosis
and 8% had another STD diagnosed, according to their
questionnaire responses or chart review (not shown);
there were no significant differences between interven-
tion and control groups.
Intervention participants reported a high level of
satisfaction with WRAP and the health educators. Large
proportions strongly agreed or agreed that it had been
FIGURE 1. Percentage ofwomenmaintaining a high level or
improving their level of contraceptive use from baseline to
12-month follow-up, by study group
FIGURE 2. Percentage of women reporting no barriers to
contraceptive use who reportedmaintaining a high level or
improving their level of use from baseline to 12 months, by
study group
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helpful to talk to the educator about contraception
(82%), that the educator had focused on their individual
concerns regarding contraception (90%) and that the
educator had addressed all of their questions adequately
(93%).
DISCUSSION
Despite significant increases in the proportions of inter-
vention and control participants reporting improvement
in or maintenance of a high level of contraceptive use at
the two-month follow-up, we found no long-term effects
of the intervention or significant differences between the
two groups. In addition, for women reporting condom
use, the intervention did not increase consistency of use.
We propose several implications of our findings. The
positive findings at twomonths and the negative findings
at eight and 12 months suggest that repeated counseling
or booster sessions may be needed to help women
maintain or improve their level of contraceptive use.
Other areas of research (e.g., nutrition,41 smoking cessa-
tion42 and physical activity43) have found the need for
repeated counseling to support positive behavior change.
The lack of improvement in consistency of condom use
may be related to a lower risk, or a lower perceived risk, of
STDs among the study participants than we expected.
Many control participants improved their level of con-
traceptive use or maintained a high level of use during the
first two months despite a lack of pregnancy and STD
prevention counseling from the WRAP health educators.
This may be related to the completion of the baseline
questionnaire, which included many questions about
contraceptive use and the risk of unintended pregnancy
and STDs. Exposure to these questionsmay have prompted
control participants to thinkmore about these issues and
to use contraceptivesmore effectively. However, if this were
the primary explanation forour findings, the completion of
questionnaires at eight and 12 months might have led
women to a continuation of their use of effective contra-
ception over the entire study period, which it did not.
Another potential explanation for the increase in the
level of contraceptive use among control participantsmay
have been changes in provider behaviors beyond the
control of the WRAP study. This study was not intended
to influence or replace provider care in the primary health
care settings. However, given the study team’s presence in
the clinics, providers were aware that patients were being
recruited into a randomized controlled trial to evaluate
a counseling intervention. Someprovidersmay have been
reminded, just by the presence of the WRAP team, to
provide counseling for pregnancy and STD prevention.
These findings support earlier research showing that
many women are at risk of unintended pregnancy and
STDs because of low levels of contraceptive use or non-
use. In this study, having less than a high level of
contraceptive use was defined as using a less effective
method, or using a method inconsistently. Our findings
also help demonstrate the difficulty of defining the
concept of unintended pregnancy and the potential for
ambivalence, given that 21%of participants were not sure
whether they wanted to become pregnant or not.
Intervention participants reported a high level of
satisfaction with the WRAP counseling and the health
educators. At weekly team meetings, the educators re-
ported many positive interactions with participants, and
the study team received positive feedback from many
health care providers in the clinical settings where the
study was evaluated. Additionally, both participants and
providers appreciated the efforts of health educators in
devoting the time to discuss the complex issues of
contraceptive use and the prevention of pregnancy and
STDs.
Strengths and Limitations
The strengths of this study include the randomized
controlled design, the 12-month follow-up period, the
high participant retention rates and the inclusion of
behavior-change theory in the design and implementa-
tion of the intervention. Limitations include the reliance
on self-reporting for contraceptive use and barriers to use.
Self-report may result in bias because participants may
underreport the amount and level of risk-taking and
nonuse or underuse of contraceptives. Participants may
also have experienced barriers to contraceptive use that
we were unable to identify with a written survey. The lack
of power to detect differences in pregnancy and chla-
mydia rates between the groupswas also a concern, given
that these outcomes occurred less frequently thanwe had
predicted. Furthermore, despite training and manage-
ment oversight to standardize the intervention delivery,
there may have been counseling inconsistencies among
the WRAP health educators. In addition, some possible
influences in the clinical settings were beyond the scope
of the study (e.g., provider knowledge, practices and
attitudes regarding contraceptive and reproductive health
counseling). These limitations restrict the conclusions
we can draw about the lack of a significant difference in
FIGURE 3. Percentage of women reporting barriers to
contraceptive use who reportedmaintaining a high level or
improving their level of use from baseline to 12 months, by
study group
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contraceptive use between the intervention and control
groups, especially after the first two months.
Conclusion
This study confirms the complexity of addressing
women’s risk of unintended pregnancy and STDs in
clinical settings, particularly the difficulty of assessing
risk, the many barriers to contraceptive use, the differ-
ences inmethod effectiveness and the factors that control
the consistency with which women use a method. Fur-
thermore, intervention participants may have benefited
more if the counseling had been continued in multiple
booster sessions. Future research should examine
whether repeated counseling enables women tomaintain
the preventive behaviors needed to reduce their risk of
unintended pregnancy and STDs. If such counseling is
found to reduce women’s sexual and reproductive risks,
an economic evaluation of the costs and benefits will help
in assessing whether the wider provision of pregnancy
and STD prevention counseling can make a significant
contribution to improving women’s reproductive health.
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